Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-10-13
DOI
10.1093/ndt/gfx313
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review
- (2017) Ching-Wei Tsai et al. PLoS One
- Effect of Uric Acid–Lowering Agents on Endothelial FunctionNovelty and Significance
- (2016) Lea Borgi et al. HYPERTENSION
- Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial
- (2015) Dipankar Sircar et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Direct Radical Scavenging Activity of Benzbromarone Provides Beneficial Antioxidant Properties for Hyperuricemia Treatment
- (2015) Daisuke Kadowaki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
- (2015) Tahir Kanji et al. BMC Nephrology
- Cost-Effectiveness Analysis of Allopurinol Versus Febuxostat in Chronic Gout Patients: A U.S. Payer Perspective
- (2015) Pranav K. Gandhi et al. Journal of Managed Care & Specialty Pharmacy
- Association of Walking with Survival and RRT Among Patients with CKD Stages 3-5
- (2014) I.-R. Chen et al. Clinical Journal of the American Society of Nephrology
- Allopurinol for the treatment of chronic kidney disease: asystematic review
- (2014) Nigel Fleeman et al. HEALTH TECHNOLOGY ASSESSMENT
- Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction
- (2014) Yugo Shibagaki et al. HYPERTENSION RESEARCH
- Effect of uric-acid-lowering therapy on progression of chronic kidney disease: A meta-analysis
- (2014) Ye-fang Zhang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Allopurinol in Renal Ischemia
- (2014) Beatriz Prieto-Moure et al. JOURNAL OF INVESTIGATIVE SURGERY
- The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study
- (2014) Tatsuo Hosoya et al. Trials
- Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
- (2014) Johji Nomura et al. Scientific Reports
- Progression of stages 3b–5 chronic kidney disease—Preliminary results of Taiwan National Pre-ESRD Disease Management Program in Southern Taiwan
- (2013) Chun-Mei Lin et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
- (2013) Bhadran Bose et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A Randomized Study of Allopurinol on Endothelial Function and Estimated Glomular Filtration Rate in Asymptomatic Hyperuricemic Subjects with Normal Renal Function
- (2011) M. Kanbay et al. Clinical Journal of the American Society of Nephrology
- Biomarkers in chronic kidney disease: a review
- (2011) Robert G. Fassett et al. KIDNEY INTERNATIONAL
- Gout
- (2011) Tuhina Neogi NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Benzbromarone in Hyperuricemic Patients Associated with Chronic Kidney Disease
- (2011) S. Fujimori et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
- (2010) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- New Agents for the Treatment of Gout and Hyperuricemia: Febuxostat, Puricase, and Beyond
- (2010) Naomi Schlesinger Current Rheumatology Reports
- A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout
- (2009) Ming-Han H Lee et al. DRUG SAFETY
- Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
- (2007) Sima Halevy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now